AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇿
Ocrelizumab in Tanzania
1 product registered with TMDA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| OCREVUS Solution for Injection and Infusion | TAN 23 HM 0070 | F.Hoffmann-La Roche Limited | active | — |
Ocrelizumab — TMDA Registration Details
TMDA (Tanzania) has 1 registered product containing Ocrelizumab, of which 1 is currently active. Data is sourced directly from the official TMDA drug register and refreshed daily.
Track Ocrelizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.